Ghislain Bidaut

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

Fabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaïssi et al. · Proceedings of the National Academy of Sciences · 2015 · 464 citations · Full text

Medicine, Oncology, Pharmacology +17

miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling

Rita El Helou, Guillaume Pinna, Olivier Cabaud et al. · Cell Reports · 2017 · 128 citations · Full text

Medicine, Molecular Biology, Oncology +17

Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling

Véronique Secq, Julie Leca, Christian Bressy et al. · Cell Death and Disease · 2015 · 88 citations · Full text

Medicine, Neuroscience, Oncology +17

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression

Victoire Gouirand, Tristan Gicquel, Evan C. Lien et al. · The EMBO Journal · 2022 · 70 citations · Full text

Medicine, Biochemistry, Oncology +9

High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes

Ismahane Bekhouche, Pascal Finetti, José Adélaı̈de et al. · PLoS ONE · 2011 · 65 citations · Full text

Life Sciences, Genetics, Molecular Biology +17